Tiresias: On Augury

"It is very hard to predict – especially the future."

Niels Bohr

My friends,

Tiresias has pondered the recent movements in the Optiscan share price. He would like to remind his friends he predicted that, because of an overhang of shares held by previous management and directors, there would be pressure on the price. And there has been. Tiresias trusts his friends remembered this and that they were not too concerned that something might have been wrong. Tiresias understands that nobody likes seeing the price of their stock going down. It is disconcerting to see friends who were buyers at 20c become sellers at 15, and panic sellers at 12c. But if it shakes out the weak or fake holders, Tiresias considers this a very big plus ensuring that when the rise comes it will be all the sharper and all the higher. Tiresias can assure his friends, that though like them, he doesn’t particularly like a lower price, he is not concerned.

Way back in the mythic past, Tiresias’s prophesies were questioned, and his predictions attacked. You might recall when Oedipus accused him of being a false prophet when he divined to the cause of the plague in Thebes. Fear not my friends, Tiresias is the very model of a modern futurologist. Though he still uses all the traditional methods of augury he is very familiar with all the sciences, medicine, and medical technology. Fear not the truth of his predictions regarding Optiscan. These are plain to see and are easy to foresee. These things are not hard. What is hard in predictions is to figure the behaviour of mortals. To this end, Tiresias is also a student of human nature, bizarre as that is. Compared to the behaviour of mortals, prediction applied in the context of sciences such as medicine, engineering and even that most unpredictable, of all weather and climate is easy, when compared to the predictions of the follies of men. One just has to realise Optiscan Confocal Laser Endomicroscopy (CLE), is the next big thing in cancer diagnosis and cancer surgery. Tiresias is sure of the financial power that is now behind Optiscan, and has faith and confidence in the transformative changes in the strengths and strengthening of the new board and management which will soon show up and show up in the share price, and how.